la cause de décès est restée indéterminée pour un nombre non négligeable de patients ,
4% des décès) Pour cette raison, nous n'avons pas pratiqué d'analyse complémentaire sur la survie spécifique ,
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013- 10/guide_k_bronchopulmonaires_finalweb__091013.pdf. 5. National Lung Screening Trial Research Team et al. Reduced lung-cancer mortality with lowdose computed tomographic screening, N. Engl. J. Med, vol.365, pp.395-409, 2011. ,
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers, The Lancet Oncology, vol.15, issue.12, pp.1342-1350, 2014. ,
DOI : 10.1016/S1470-2045(14)70387-0
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), The Lancet, vol.387, issue.10026, pp.1415-1426, 2016. ,
DOI : 10.1016/S0140-6736(16)00004-0
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis, British Journal of Cancer, vol.27, issue.Suppl 3, pp.131-139, 2005. ,
DOI : 10.1016/S0033-0620(85)80003-7
Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis, Lung Cancer, vol.81, issue.1, pp.1-10, 2013. ,
DOI : 10.1016/j.lungcan.2013.03.019
Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy 11. Yagishita, S. et al. Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer, Lung Cancer Int. Cancer Sci, vol.2012, issue.106, pp.1-6, 2012. ,
Natural History of Stage I Non-Small Cell Lung Cancer, Chest, vol.132, issue.1, pp.193-199, 2007. ,
DOI : 10.1378/chest.06-3096
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review, ESMO Consensus Conference on Lung Cancer: early-stage nonsmall-cell lung cancer consensus on diagnosis, pp.628-638, 2001. ,
Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non???Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis, Journal of Clinical Oncology, vol.28, issue.35, pp.5153-5159, 2010. ,
DOI : 10.1200/JCO.2010.30.0731
Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates, Acta Oncologica, vol.32, issue.7049, pp.1552-1558, 2013. ,
DOI : 10.1159/000324113
Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.95, issue.5, pp.1378-1390, 2016. ,
DOI : 10.1016/j.ijrobp.2016.04.016
Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months, Journal of Thoracic Oncology, vol.11, issue.7, pp.1101-1111, 2016. ,
DOI : 10.1016/j.jtho.2016.03.021
Quality of life during 5 years after stereotactic radiotherapy in stage I nonsmall cell lung cancer 24. van der Voort van Zyp, N. C. et al. Quality of Life After Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer, 25. Nagata, Y. et al. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403, pp.31-37, 2010. ,
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927), International Journal of Radiation Oncology*Biology*Physics, vol.93, issue.4, pp.757-764, 2015. ,
DOI : 10.1016/j.ijrobp.2015.07.2260
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer, JAMA, vol.303, issue.11 ,
DOI : 10.1001/jama.2010.261
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial, Lung Cancer, vol.68, issue.1, pp.72-77, 2010. ,
DOI : 10.1016/j.lungcan.2009.05.007
Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer, Radiotherapy and Oncology, vol.93, issue.3, pp.402-407, 2006. ,
DOI : 10.1016/j.radonc.2009.06.002
Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non???Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy, Journal of Clinical Oncology, vol.27, issue.20, pp.3290-3296, 2009. ,
DOI : 10.1200/JCO.2008.21.5681
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer ??? A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study, Radiotherapy and Oncology, vol.88, issue.3, pp.359-367, 2008. ,
DOI : 10.1016/j.radonc.2008.07.019
Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer, Journal of Clinical Oncology, vol.24, issue.30, pp.4833-4839, 2006. ,
DOI : 10.1200/JCO.2006.07.5937
A Pilot Trial of Serial 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Medically Inoperable Stage I Non???Small-Cell Lung Cancer Treated With Hypofractionated Stereotactic Body Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.789-795, 2010. ,
DOI : 10.1016/j.ijrobp.2009.02.051
Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.2, pp.404-409, 2008. ,
DOI : 10.1016/j.ijrobp.2007.12.051
A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer, Radiotherapy and Oncology, vol.85, issue.3, pp.429-434, 2005. ,
DOI : 10.1016/j.radonc.2007.10.017
Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC), Acta Oncologica, vol.106, issue.1, pp.796-801, 2006. ,
DOI : 10.1002/cncr.21747
Dose???Response for Stereotactic Body Radiotherapy in Early-Stage Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.299-303, 2011. ,
DOI : 10.1016/j.ijrobp.2011.01.038
Stereotactic body radiation therapy of early-stage non???small-cell lung carcinoma: Phase I study, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.4, pp.1010-1015, 2005. ,
DOI : 10.1016/j.ijrobp.2005.03.073
Extracranial Stereotactic Radioablation *, Chest, vol.124, issue.5, pp.1946-1955, 2003. ,
DOI : 10.1378/chest.124.5.1946
Stereotactic single-dose radiotherapy of stage I non???small-cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.2, pp.335-341, 2003. ,
DOI : 10.1016/S0360-3016(02)04504-2
Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive Patients, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.967-973, 2012. ,
DOI : 10.1016/j.ijrobp.2010.12.039
Survival and Quality of Life After Stereotactic or 3D-Conformal Radiotherapy for Inoperable Early-Stage Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.291-297, 2011. ,
DOI : 10.1016/j.ijrobp.2011.03.052
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis, The Lancet Oncology, vol.13, issue.8, pp.802-809, 2012. ,
DOI : 10.1016/S1470-2045(12)70242-5
Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non???Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis, Journal of Thoracic Oncology, vol.8, issue.8, pp.1050-1058, 2013. ,
DOI : 10.1097/JTO.0b013e318293dc45
Dose???Response Relationship for Image-Guided Stereotactic Body Radiotherapy of Pulmonary Tumors: Relevance of 4D Dose Calculation, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.1, pp.47-54, 2009. ,
DOI : 10.1016/j.ijrobp.2008.06.1939
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry, Journal of Radiation Oncology, vol.52, issue.7, pp.55-63, 2015. ,
DOI : 10.3109/0284186X.2013.813635
Prediction of Early Death in Patients with Early-Stage NSCLC???Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?, Journal of Thoracic Oncology, vol.11, issue.7 ,
DOI : 10.1016/j.jtho.2016.03.016
Dose???response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance, Radiotherapy and Oncology, vol.110, issue.3, pp.499-504, 2014. ,
DOI : 10.1016/j.radonc.2014.02.002
A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non???Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy, Journal of Thoracic Oncology, vol.7, issue.9, pp.1382-1393, 2012. ,
DOI : 10.1097/JTO.0b013e318260e00d
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study, Lung Cancer, vol.84, issue.3, pp.248-253, 2014. ,
DOI : 10.1016/j.lungcan.2014.02.015
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries, Acta Oncologica, vol.53, issue.3, pp.787-795, 2006. ,
DOI : 10.1055/s-2005-837631
Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer, Lung Cancer, vol.92, pp.47-52, 2016. ,
DOI : 10.1016/j.lungcan.2015.12.003
Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non???Small-Cell Lung Cancer: Implications for Surveillance, Clinical Lung Cancer, vol.17, issue.3, pp.177-183, 2016. ,
DOI : 10.1016/j.cllc.2015.09.006
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non???Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy, Clinical Lung Cancer, vol.17, issue.1, pp.39-46, 2016. ,
DOI : 10.1016/j.cllc.2015.07.007
Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients, PLOS ONE, vol.81, issue.7, p.133617, 2015. ,
DOI : 10.1371/journal.pone.0133617.t003
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer, Lung Cancer, vol.89, issue.2, pp.115-120, 2015. ,
DOI : 10.1016/j.lungcan.2015.05.019
Stereotactic Body Radiotherapy Using a Radiobiology-Based Regimen for Stage I Non???Small-Cell Lung Cancer: Five-Year Mature Results, Journal of Thoracic Oncology, vol.10, issue.6, pp.960-964, 2015. ,
DOI : 10.1097/JTO.0000000000000525
Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer, Cancer, vol.79, issue.suppl, pp.2078-2084, 2012. ,
DOI : 10.1080/09553000310001609224
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size, Radiation Oncology, vol.5, issue.1, p.1, 2010. ,
DOI : 10.1186/1748-717X-5-81
Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis, Technology in Cancer Research & Treatment, vol.14, issue.6, pp.667-676, 2015. ,
DOI : 10.7785/tcrt.2012.500445
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.11 ,
DOI : 10.1097/JTO.0000000000000662
Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis, European Journal of Cancer, vol.50, issue.17, pp.2932-2938, 1990. ,
DOI : 10.1016/j.ejca.2014.09.006
Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac, Radiotherapy and Oncology, vol.112, issue.3, pp.360-364, 2014. ,
DOI : 10.1016/j.radonc.2014.08.003
Patterns of Disease Recurrence after SABR for Early Stage ,
Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer, Journal of Thoracic Oncology, vol.7, issue.7, pp.1148-1154, 2012. ,
DOI : 10.1097/JTO.0b013e318252cfef
Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer, Journal of Thoracic Oncology, vol.6, issue.12, pp.2052-2057, 2011. ,
DOI : 10.1097/JTO.0b013e3182307e74
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.3, pp.685-692, 2008. ,
DOI : 10.1016/j.ijrobp.2007.10.053
Lung Stereotactic Body Radiation Therapy: Regional Nodal Failure Is Not Predicted by Tumor Size, Journal of Thoracic Oncology, vol.9, issue.11, pp.1693-1697, 2014. ,
DOI : 10.1097/JTO.0000000000000313
URL : https://doi.org/10.1097/jto.0000000000000313
Stereotactic Ablative Radiation Therapy for Centrally Located Early Stage or Isolated Parenchymal Recurrences of Non-Small Cell Lung Cancer: How to Fly in a ???No Fly Zone???, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5 ,
DOI : 10.1016/j.ijrobp.2014.01.022
Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer, Cancer, vol.104, issue.18, pp.3402-3410, 2013. ,
DOI : 10.1016/j.radonc.2012.01.014
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer, Radiation Oncology, vol.7, issue.1, 2012. ,
DOI : 10.1016/j.radonc.2010.04.011
Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates, Acta Oncologica, vol.32, issue.7049, pp.1552-1558, 2013. ,
DOI : 10.1159/000324113
Stereotactic body radiotherapy using gated radiotherapy with real-time tumortracking for stage I non-small cell lung cancer, Radiat. Oncol, vol.8, p.1, 2013. ,
Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer, Lung Cancer, vol.77, issue.1, pp.77-82, 2012. ,
DOI : 10.1016/j.lungcan.2012.01.006
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer, Lung Cancer, vol.79, issue.3, pp.248-253, 2013. ,
DOI : 10.1016/j.lungcan.2012.11.008
Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.86, issue.2, pp.257-263, 2013. ,
DOI : 10.1016/j.ijrobp.2013.01.006
Stereotactic Body Radiotherapy for Primary Lung Cancer at a Dose of 50 Gy Total in Five Fractions to the Periphery of the Planning Target Volume Calculated Using a Superposition Algorithm, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.2, pp.442-448, 2009. ,
DOI : 10.1016/j.ijrobp.2008.04.043
Residual 18F-FDG-PET Uptake 12 Weeks After Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Predicts Local Control, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.4, pp.551-555, 2012. ,
DOI : 10.1016/j.ijrobp.2012.01.012
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials, The Lancet Oncology, vol.16, issue.6, pp.630-637, 2010. ,
DOI : 10.1016/S1470-2045(15)70168-3
Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors, Radiotherapy and Oncology, vol.99, issue.1, pp.18-22, 2011. ,
DOI : 10.1016/j.radonc.2011.03.003
Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC], Zhongguo Fei Ai Za Zhi Chin. J. Lung Cancer, vol.19, pp.136-146, 2016. ,
Survival Outcome After Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: A Meta-Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.90, issue.3, pp.603-611, 2014. ,
DOI : 10.1016/j.ijrobp.2014.05.055
Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.152, issue.1, pp.44-54, 2016. ,
DOI : 10.1016/j.jtcvs.2016.03.060
Treatment Outcomes in Stage I Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.12, pp.1776-1784, 2015. ,
DOI : 10.1097/JTO.0000000000000680
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta ??? A population-based study, Radiotherapy and Oncology, vol.117, issue.1, pp.71-76, 2015. ,
DOI : 10.1016/j.radonc.2015.08.027
Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer, Cancer, vol.23, issue.14, pp.2341-2349, 2015. ,
DOI : 10.1016/S0272-5231(03)00063-7
Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer, Journal of Thoracic Oncology, vol.10, issue.8, pp.1201-1206, 2015. ,
DOI : 10.1097/JTO.0000000000000600
Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non???Small Cell Lung Cancers in the Elderly, JAMA Surgery, vol.149, issue.12, p.1244, 2014. ,
DOI : 10.1001/jamasurg.2014.556
Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery, Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer. Respir. Investig, pp.240-244, 2011. ,
DOI : 10.1016/j.radonc.2011.06.029
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC, Journal of Thoracic Oncology, vol.10, issue.5, pp.826-831, 2015. ,
DOI : 10.1097/JTO.0000000000000483
Survival and Treatment of Non-small Cell Lung Cancer Stage I???II Treated Surgically or with Stereotactic Body Radiotherapy: Patient and Tumor-Specific Factors Affect the Prognosis, Annals of Surgical Oncology, vol.144, issue.5, pp.316-323, 2015. ,
DOI : 10.1016/j.cell.2011.02.013
Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer, The Annals of Thoracic Surgery, vol.99, issue.4, pp.1122-1129, 2015. ,
DOI : 10.1016/j.athoracsur.2014.11.009
Stage I???II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis, Annals of Oncology, vol.24, issue.6, pp.1543-1548, 2013. ,
DOI : 10.1093/annonc/mdt026
Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non???Small-Cell Lung Cancer, Journal of Thoracic Oncology, vol.8, issue.2, pp.192-201, 2013. ,
DOI : 10.1097/JTO.0b013e31827ce361
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis, The Journal of Thoracic and Cardiovascular Surgery, vol.143, issue.2, pp.428-436, 2012. ,
DOI : 10.1016/j.jtcvs.2011.10.078
Stereotactic body radiation therapy versus surgical resection for stage I non???small cell lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.140, issue.2, pp.377-386, 2010. ,
DOI : 10.1016/j.jtcvs.2009.12.054
Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer, JNCI Journal of the National Cancer Institute, vol.89, issue.23, pp.1782-1788, 1997. ,
DOI : 10.1093/jnci/89.23.1782
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.25, issue.suppl 3 ,
DOI : 10.1093/annonc/mdu199
Stereotactic body radiation therapy in the treatment of multiple primary lung cancers, Radiotherapy and Oncology, vol.104, issue.1, pp.19-22, 2012. ,
DOI : 10.1016/j.radonc.2011.12.005
Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery, Radiotherapy and Oncology, vol.107, issue.3, pp.403-408, 2013. ,
DOI : 10.1016/j.radonc.2013.04.026
Metachronous and Synchronous Primary Lung Cancers: Diagnostic Aspects, Surgical Treatment, and Prognosis, Clinical Lung Cancer, vol.16, issue.1, pp.15-23, 2015. ,
DOI : 10.1016/j.cllc.2014.07.001
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, vol.82, issue.2, pp.197-203, 2013. ,
DOI : 10.1016/j.lungcan.2013.07.026
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy, Journal of Clinical Oncology, vol.31, issue.11, pp.1384-1390, 2013. ,
DOI : 10.1200/JCO.2012.45.9651
Lung stereotactic radiotherapy for oligometastases: comparison of oligorecurrence and sync-oligometastases. Jpn, J. Clin. Oncol, 2016. ,
Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases, Pulmonary Medicine, vol.28, issue.6, pp.1-5, 2012. ,
DOI : 10.1016/j.radonc.2012.01.011
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases, The Journal of Thoracic and Cardiovascular Surgery, vol.113, issue.1, pp.37-49, 1997. ,
DOI : 10.1016/S0022-5223(97)70397-0
Stereotactic body radiotherapy for multisite extracranial oligometastases, Cancer, vol.366, issue.3 suppl, pp.2962-2970, 2012. ,
DOI : 10.1016/S0140-6736(05)66954-1
URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.26611/pdf
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study, Radiation Oncology, vol.7, issue.1, 2012. ,
DOI : 10.1016/j.lungcan.2006.12.009
Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases, Journal of Clinical Oncology, vol.27, issue.10, pp.1585-1591, 2009. ,
DOI : 10.1200/JCO.2008.20.0600
Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1???2 trial, The Lancet Oncology, vol.13, issue.4, pp.395-402, 2012. ,
DOI : 10.1016/S1470-2045(11)70384-9
Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases, Cancer, vol.70, issue.22 suppl, pp.5069-5077, 2012. ,
DOI : 10.1016/j.ijrobp.2007.10.059
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases, Journal of Clinical Oncology, vol.27, issue.10, pp.1572-1578, 2009. ,
DOI : 10.1200/JCO.2008.19.6329
Interim analysis of a prospective phase I/II trial of SBRT for liver metastases, Acta Oncologica, vol.76, issue.7, pp.848-855, 2006. ,
DOI : 10.1007/s00104-005-1039-5
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases, Journal of Clinical Oncology, vol.27, issue.10, pp.1579-1584, 2009. ,
DOI : 10.1200/JCO.2008.19.6386
Stereotactic Body Radiation Therapy (SBRT) for lung metastases, Acta Oncologica, vol.57, issue.7, pp.808-817, 2006. ,
DOI : 10.1016/S0360-3016(03)00846-0
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments, Radiation Oncology, vol.9, issue.1, p.1, 2014. ,
DOI : 10.1097/JTO.0b013e31824166a5
Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.3, pp.878-886, 2012. ,
DOI : 10.1016/j.ijrobp.2011.08.036
Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy, Breast Cancer Research and Treatment, vol.104, issue.3, pp.601-608, 2009. ,
DOI : 10.1016/j.ijrobp.2006.10.025
A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions, Cancer, vol.64, issue.3, pp.650-658, 2008. ,
DOI : 10.1016/j.ijrobp.2006.10.025
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients, Annals of Oncology, vol.25, issue.10, pp.1954-1959, 2014. ,
DOI : 10.1093/annonc/mdu370
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial, BMC Cancer, vol.16, issue.2, p.305, 2012. ,
DOI : 10.1016/j.semradonc.2005.12.002
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer, Annals of Oncology, vol.26, issue.4 ,
DOI : 10.1093/annonc/mdu584
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer, Annals of Oncology, vol.26, issue.4 ,
DOI : 10.1093/annonc/mdu584
Radical Treatment of Non???Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450), Journal of Thoracic Oncology, vol.7, issue.10, pp.1547-1555, 2012. ,
DOI : 10.1097/JTO.0b013e318262caf6
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients, Annals of Oncology, vol.25, issue.10, pp.1954-1959, 2014. ,
DOI : 10.1093/annonc/mdu370
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.15, issue.5, pp.346-355, 2014. ,
DOI : 10.1016/j.cllc.2014.04.003
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, vol.82, issue.2, pp.197-203, 2013. ,
DOI : 10.1016/j.lungcan.2013.07.026
Which Is the Optimal Biologically Effective Dose of Stereotactic Body Radiotherapy for Stage I Non???Small-Cell Lung Cancer? A Meta-Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.305-316, 2011. ,
DOI : 10.1016/j.ijrobp.2011.04.034
Increasing Radiation Therapy Dose Is Associated With Improved Survival in Patients Undergoing Stereotactic Body Radiation Therapy for Stage I??Non???Small-Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.91, issue.2, pp.344-350, 2015. ,
DOI : 10.1016/j.ijrobp.2014.10.002
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study, Journal of Thoracic Oncology, vol.2, issue.7, pp.94-100, 2007. ,
DOI : 10.1097/JTO.0b013e318074de34
Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control, Practical Radiation Oncology, vol.2, issue.4, pp.288-295, 2012. ,
DOI : 10.1016/j.prro.2011.10.004
Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery, Radiation Oncology Journal, vol.33, issue.4, p.265, 2015. ,
DOI : 10.3857/roj.2015.33.4.265
The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.87, issue.5, pp.1064-1070, 2013. ,
DOI : 10.1016/j.ijrobp.2013.08.020
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries, Acta Oncologica, vol.53, issue.3, pp.787-795, 2006. ,
DOI : 10.1055/s-2005-837631
Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non???Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis, Journal of Thoracic Oncology, vol.9, issue.6, pp.834-842, 2014. ,
DOI : 10.1097/JTO.0000000000000185
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.5, issue.5 ,
DOI : 10.1097/JTO.0b013e3181d0a4f5
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project, Journal of Thoracic Oncology, vol.3, issue.1, pp.6-12, 2008. ,
DOI : 10.1097/JTO.0b013e31815e6d6b
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis, PLOS ONE, vol.31, issue.30, p.146195, 2016. ,
DOI : 10.1371/journal.pone.0146195.s002
Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.285, issue.7, pp.241-251, 2015. ,
DOI : 10.1097/MNM.0b013e3283599999
Volume-based Parameters Measured by Using FDG PET/CT in Patients with Stage I NSCLC Treated with Stereotactic Body Radiation Therapy: Prognostic Value, Radiology, vol.270, issue.1, pp.275-281, 2014. ,
DOI : 10.1148/radiol.13130652
Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience, Journal of Radiation Research, vol.54, issue.1, pp.108-112, 2013. ,
DOI : 10.1093/jrr/rrs075
Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer, Practical Radiation Oncology, vol.3, issue.4, pp.301-306, 2013. ,
DOI : 10.1016/j.prro.2012.10.003
Stereotactic body radiation therapy for stage I small cell lung cancer: a single institutional case series and review of the literature, Journal of Radiation Oncology, vol.24, issue.7, pp.285-291, 2014. ,
DOI : 10.1097/JTO.0b013e3181cd3208
Multi-institutional Retrospective Study of Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer: Japan Radiation Oncology Study Group (JROSG), International Journal of Radiation Oncology*Biology*Physics, vol.93, issue.3, p.101, 2015. ,
DOI : 10.1016/j.ijrobp.2015.07.243
Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study, Medical Oncology, vol.102, issue.30, p.369, 2014. ,
DOI : 10.1016/j.radonc.2011.12.023
Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study, Medical Oncology, vol.102, issue.30, p.31, 2014. ,
DOI : 10.1016/j.radonc.2011.12.023
Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience, Journal of Radiation Research, vol.54, issue.1, pp.108-112, 2013. ,
DOI : 10.1093/jrr/rrs075
Outcomes by Tumor Histology and KRAS Mutation Status After Lung Stereotactic Body??Radiation Therapy for Early-Stage Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.16, issue.1, pp.24-32, 2015. ,
DOI : 10.1016/j.cllc.2014.09.005